State MO
Clinical Trials in Missouri
Recruiting clinical trials with at least one study location in Missouri. Data updated daily from ClinicalTrials.gov.
Top Conditions in Missouri
Frequently Asked Questions — Clinical Trials in Missouri
How many clinical trials are currently recruiting in Missouri?
ClinicalMetric currently tracks 296 actively recruiting clinical trials with at least one location in Missouri. The total number of registered studies—including active but not currently enrolling trials—is 296. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Missouri?
Missouri hosts clinical trials across a broad range of medical conditions, including Multiple Myeloma, Advanced Solid Tumor, Breast Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Missouri serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Missouri?
To join a clinical trial in Missouri, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Missouri maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Missouri
NCT05692180 Phase 3
Recruiting
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Tim...
Condition
Asthma
Enrollment
200 pts
Location
United States, Argentina, Canada
Sponsor
AstraZeneca
NCT06908356 Phase 2
Recruiting
An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults Wi...
Condition
Focal Onset Seizure
Enrollment
50 pts
Location
United States, Australia, Spain
Sponsor
Praxis Precision Medicines
NCT02763683 N/A
Recruiting
Investigations of Dementia in Parkinson Disease
Condition
Parkinsons
Enrollment
320 pts
Location
United States
Sponsor
Washington University School o
NCT06143956 Phase 2
Recruiting
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices ...
Condition
Obesity
Enrollment
1,217 pts
Location
United States, Argentina
Sponsor
Eli Lilly and Company
NCT06926920 Phase 1, Phase 2
Recruiting
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Pa...
Condition
Triple Negative Breast Cancer
Enrollment
100 pts
Location
United States, Australia, South Korea
Sponsor
Gilead Sciences
NCT06963827 Phase 3
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Condition
Kidney Disease
Enrollment
347 pts
Location
United States, Argentina, Australia
Sponsor
Takeda
NCT05582551 N/A
Recruiting
Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Scree...
Condition
Childhood Cancer
Enrollment
146 pts
Location
United States
Sponsor
Washington University School o
NCT05611242 Phase 3
Recruiting
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlu...
Condition
Acute Ischemic Stroke
Enrollment
404 pts
Location
United States
Sponsor
Mercy Health Ohio
NCT07191483 Phase 2
Recruiting
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With...
Condition
Cognitive Impairment Associated With Schizophrenia (CIAS)
Enrollment
150 pts
Location
United States
Sponsor
Kynexis B.V.
NCT05580562 Phase 3
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study...
Condition
H3 K27M
Enrollment
510 pts
Location
United States, Argentina, Australia
Sponsor
Jazz Pharmaceuticals
NCT05555069 N/A
Recruiting
The Impact of Menthol Flavoring on Switching in Adult Menthol Smokers
Condition
Smoking Reduction
Enrollment
800 pts
Location
United States
Sponsor
Nikki Nollen, PhD, MA
NCT04629469 N/A
Recruiting
Low Field and High Field Magnetic Resonance Imaging Assessments on Pediatric Pat...
Condition
Conditions Requiring a Brain Magnetic Resonance Imaging, Head Computerized Tomography, or Head Ultrasound
Enrollment
250 pts
Location
United States
Sponsor
Children's Mercy Hospital Kans
NCT02852031 N/A
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart...
Condition
Hypoplastic Left Heart Syndrome (HLHS)
Enrollment
1,000 pts
Location
United States, Canada, United Kingdom
Sponsor
Children's Hospital Medical Ce
NCT07052942 Phase 4
Recruiting
Individualizing Treatment for Asthma in Primary Care (Full Study)
Condition
Asthma
Enrollment
3,200 pts
Location
United States
Sponsor
DARTNet Institute
NCT03803423 N/A
Recruiting
Dissemination of the Donor Application: Utilizing Social Media to Identify Poten...
Condition
End Stage Renal Disease
Enrollment
1,000 pts
Location
United States
Sponsor
Johns Hopkins University
NCT06395103 Phase 1, Phase 2
Recruiting
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants Wit...
Condition
B-cell Acute Lymphoblastic Leukemia
Enrollment
90 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
NCT04239573 N/A
Recruiting
Comparing Two Methods to Follow Patients With Pancreatic Cysts
Condition
Pancreatic Carcinoma
Enrollment
4,606 pts
Location
United States, Canada, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT03999983 N/A
Recruiting
Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER)
Condition
Vertebral Artery Stenosis
Enrollment
150 pts
Location
United States
Sponsor
St. Louis University
NCT07455383 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolep...
Condition
Narcolepsy Type 1
Enrollment
150 pts
Location
United States
Sponsor
Alkermes, Inc.
NCT05896839 Phase 1, Phase 2
Recruiting
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant...
Condition
Clinical Stage III Cutaneous Melanoma AJCC v8
Enrollment
16 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06980480 Phase 3
Recruiting
A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infection...
Condition
Multiple Myeloma
Enrollment
183 pts
Location
United States, Australia, Austria
Sponsor
Takeda
NCT06894979 Phase 1
Recruiting
Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy f...
Condition
Childhood Astrocytoma
Enrollment
54 pts
Location
United States
Sponsor
Children's Oncology Group
NCT07215624 N/A
Recruiting
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Netw...
Condition
Malignant Digestive System Neoplasm
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
NCT06993610 Phase 2
Recruiting
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Condition
Hidradenitis Suppurativa (HS)
Enrollment
225 pts
Location
United States, Canada, Germany
Sponsor
Zura Bio Inc
NCT06910670 N/A
Recruiting
Implementing a Randomized Control Trial to Test the Expanded Web-based Decision ...
Condition
Cholangiocarcinoma
Enrollment
240 pts
Location
United States
Sponsor
Washington University School o
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology